Scientists stumble across new method of making antibiotics

July 13, 2017
A colorized scanning electron micrograph of MRSA. Credit: National Institute of Allergy and Infectious Diseases

Cancer researchers in the UK may have stumbled across a solution to reverse antibiotic drug resistance and stop infections like MRSA.

Experts warn we are decades behind in the race against superbugs having already exploited naturally occurring antibiotics, with the creation of new ones requiring time, money and ingenuity.

But a team of scientists at the University of Salford say they may have found a very simple way forward – even though they weren't even looking for antibiotics.

And they have created and validated several already – many of which are as potent, or more so, than standard antibiotics, such as amoxicillin.

"A little like Alexander Fleming, we weren't even looking for antibiotics rather researching into new compounds that might be effective against ," explains Michael P. Lisanti, Chair of Translational Medicine at the University's Biomedical Research Centre.

"I think we've accidentally invented a systemic way of creating new antibiotics which is simple, cheap and could be very significant in the fight against superbugs," added Dr Federica Sotgia, a co-author on the study.

The Salford group specialise in stem and specifically methods of inhibiting energy production in mitochondria, the "powerhouse" of cells which fuels the growth of fatal tumours.

One of the team's work streams is how antibiotics can be effective against these mitochondria, so while searching a library of compounds for potential 'ammunition', they switched the focus and started hunting for compounds that were effective against mitochondria and could be tested as antibiotics.

"Mitochondria and bacteria have a lot in common," stresses Lisanti. "We began thinking that if what we found inhibited mitochondria, it would also kill bacteria. So, these new anti-cancer agents should also be potential antibiotics.

The team sorted through 45,000 compounds, using a three-dimensional structure of the mitochondrial ribosome – first identified by Venki Ramakrishnan, a Nobel-prize winner (Cambridge, UK) and President of The Royal Society.

They identified 800 small molecules which might inhibit mitochondria based on their structural characteristics and then whittled this down to the most promising 10 compounds, which they discovered using traditional phenotypic drug screening.

Their results showed that these synthetic - without any additional chemical engineering - inhibited a broad spectrum of 5 types of common bacteria, including Streptococcus, Pseudomonas, E. coli and methicillin-resistant Staphylococcus aureus (MRSA). They also killed the pathogenic yeast, Candida albicans.

These new antibiotics are called 'Mito-riboscins' because they were found by targeting the mitochondrial ribosome in human cancer cells.

'Mito-riboscins' are equally if not more potent than standard antibiotics.

"We have accidently invented a new strategy for identifying and designing new to target drug resistant bacteria," added Professor Lisanti.

"This was under our nose. The bottleneck with antibiotic discovery has been that there was no obvious systematic starting point. We may now have one. These were discovered, by simply screening candidates first on in cancer cells."

The paper is scheduled to appear in the journal Oncotarget.

Explore further: Vitamin C and antibiotics—a new one-two punch for knocking-out cancer stem cells.

More information: Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast. Oncotarget. DOI: 10.18632/oncotarget.19084

Related Stories

Vitamin C and antibiotics—a new one-two punch for knocking-out cancer stem cells.

June 12, 2017
Cancer stem cells, which fuel the growth of fatal tumours, can be knocked out by a one-two combination of antibiotics and Vitamin C in a new experimental strategy, published by researchers at the University of Salford, UK.

New gene discovered driving drug resistance

April 4, 2017
Scientists in Salford, U.K., have identified a gene which is 'revving the engine of cancer' against the world's most common breast cancer drug.

Schoolgirl comment points to antibiotics as new cancer treatments

January 28, 2015
Professor Michael P. Lisanti, Director of the Breakthrough Breast Cancer Unit, led the research. He was inspired to look at the effects of antibiotics on the mitochondria of cancer stem cells by a conversation with his daughter ...

One-two punch may floor worst infections

March 6, 2017
McMaster University researchers have found a new way to treat the world's worst infectious diseases, the superbugs that are resistant to all known antibiotics.

Antibiotic breakthrough: Team discovers how to overcome gram-negative bacterial defenses

May 10, 2017
Scientists report that they now know how to build a molecular Trojan horse that can penetrate gram-negative bacteria, solving a problem that for decades has stalled the development of effective new antibiotics against these ...

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.